Innoviva (INVA) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 15.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -76.51% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -303.06% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.06% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -26.72% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,150.63% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | -20.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.20% |
| Sep 30, 2025 | 15.67% |
| Jun 30, 2025 | 10.92% |
| Mar 31, 2025 | 603.06% |
| Sep 30, 2024 | -61.92% |
| Jun 30, 2024 | 528.93% |
| Mar 31, 2024 | 31.79% |
| Sep 30, 2023 | 1,992,672.48% |
| Jun 30, 2023 | 12.89% |
| Mar 31, 2023 | 12.09% |
| Sep 30, 2022 | -100.00% |
| Jun 30, 2022 | -112.40% |
| Mar 31, 2022 | -151.78% |
| Sep 30, 2021 | 7.62% |
| Jun 30, 2021 | 22.44% |
| Mar 31, 2021 | -106.87% |
| Dec 31, 2020 | -108.83% |
| Sep 30, 2020 | 41.60% |
| Jun 30, 2020 | 29.61% |
| Mar 31, 2020 | 49.17% |
| Dec 31, 2019 | -6.83% |
| Sep 30, 2019 | 17.68% |
| Jun 30, 2019 | 32.52% |
| Mar 31, 2019 | 112.60% |
| Dec 31, 2018 | 826.30% |
| Sep 30, 2018 | 75.18% |
| Jun 30, 2018 | 146.86% |
| Mar 31, 2018 | 131.50% |
| Dec 31, 2017 | -37.18% |
| Sep 30, 2017 | 194.93% |
| Jun 30, 2017 | 99.25% |
| Mar 31, 2017 | 72.29% |
| Dec 31, 2016 | 118.57% |
| Sep 30, 2016 | 230.01% |
| Jun 30, 2016 | 400.09% |
| Mar 31, 2016 | 2,172.62% |
| Dec 31, 2015 | 12,711.90% |
| Sep 30, 2015 | 183.60% |
| Jun 30, 2015 | 141.47% |
| Mar 31, 2015 | 100.65% |
| Dec 31, 2014 | 100.24% |
| Sep 30, 2014 | 80.94% |
| Jun 30, 2014 | 58.41% |
| Mar 31, 2014 | 26.61% |
| Dec 31, 2013 | 84.34% |
| Sep 30, 2013 | 81.77% |
| Jun 30, 2013 | 90.41% |
| Mar 31, 2013 | -121.30% |
| Dec 31, 2012 | -18.65% |
| Sep 30, 2012 | -14.59% |
| Jun 30, 2012 | -51.45% |
| Mar 31, 2012 | 506.06% |
| Dec 31, 2011 | -98.91% |
| Sep 30, 2011 | -47.93% |
| Jun 30, 2011 | -21.90% |